Revimmune Overview
- Year Founded
-
2006

- Status
-
Acquired/Merged
- Employees
-
2

- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Revimmune General Information
Description
Developer of therapies for autoimmune diseases. The Company's lead antineoplastic technology employs a bioengineered poliovirus construct and targets cancerous central nervous cells with great specificity recombinant poliovirus therapy has the potential to significantly reduce or eliminate current chemotherapy side-effects while completely destroying abnormal cancerous tissue.
Contact Information
Corporate Office
- 324 South Hyde Park Avenue
- Suite 350
- Tampa, FL 33606
- United States
Corporate Office
- 324 South Hyde Park Avenue
- Suite 350
- Tampa, FL 33606
- United States
Revimmune Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Revimmune Patents
Revimmune Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3065772-A1 | Combinations of checkpoint inhibitors and therapeutics to treat cancer | Active | 05-Nov-2013 | ||
US-20150202291-A1 | Combinations of checkpoint inhibitors and therapeutics to treat cancer | Inactive | 05-Nov-2013 | ||
US-20150273033-A1 | Combinations of checkpoint inhibitors and therapeutics to treat cancer | Inactive | 05-Nov-2013 | ||
EP-3065772-A4 | Combinations of checkpoint inhibitors and therapeutics to treat cancer | Active | 05-Nov-2013 | ||
CA-2929407-A1 | Combinations of checkpoint inhibitors and therapeutics to treat cancer | Pending | 05-Nov-2013 | A61F7/00 |
Revimmune Signals
Revimmune Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Revimmune FAQs
-
When was Revimmune founded?
Revimmune was founded in 2006.
-
Where is Revimmune headquartered?
Revimmune is headquartered in Tampa, FL.
-
What is the size of Revimmune?
Revimmune has 2 total employees.
-
What industry is Revimmune in?
Revimmune’s primary industry is Biotechnology.
-
Is Revimmune a private or public company?
Revimmune is a Private company.
-
What is Revimmune’s current revenue?
The current revenue for Revimmune is
. -
Who are Revimmune’s investors?
Johns Hopkins Technology Ventures and The Hopkins Capital Group have invested in Revimmune.
-
When was Revimmune acquired?
Revimmune was acquired on 27-Feb-2007.
-
Who acquired Revimmune?
Revimmune was acquired by Accentia Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »